Highlights from the latest articles in pharmacogenomics of irinotecan/cisplatin toxicity.
Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. gj.peters@vumc.nl
Godefridus J
GJ
Peters
Elisa
E
Giovannetti
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics*; D027682:Cation Transport Proteins / Q000235:genetics*; D002945:Cisplatin / Q000009:adverse effects*; D005260:Female; D005838:Genotype; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics*; D008297:Male
D000970:Antineoplastic Agents; D027682:Cation Transport Proteins; D002945:Cisplatin